Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy

Journal of the American College of Cardiology

Volumn 30, Issue 2, 1997, Pages 576-584

  Pak, Peter H ^a   Nuss, H Bradley ^a   Tunin, Richard S ^a   Kääb, Stefan ^a   Tomaselli, Gordon F ^a   Marban, Eduardo ^a   Kass, David A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTION POTENTIAL; AFTERHYPERPOLARIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ELECTROCARDIOGRAM; GENETIC HETEROGENEITY; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART PACING; HEART REPOLARIZATION; HOLTER MONITORING; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; SUDDEN DEATH;

ANIMALS; CARDIOMYOPATHY, DILATED; CESIUM; CHLORIDES; DEATH, SUDDEN, CARDIAC; DOGS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART FAILURE, CONGESTIVE; MALE; TACHYCARDIA;

EID: 0030835633     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00193-9     Document Type: Article

References (50)

1. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and heart failure. N Engl J Med. 325:1991;293-302.
2. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310.
3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
4. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 88:1993;2953-2961.
5. Tomaselli GF, Beuckelmann DJ, Calkins HG, et al. Sudden cardiac death in heart failure the role of abnormal repolarization . Circulation. 90:1994;2534-2539.
6. Aronson RS. Characteristics of action potentials of hypertrophied myocardium from rats with renal hypertension. Circ Res. 47:1980;443-454.
7. Gwathmey JK, Copelas L, MacKinnon R, et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 61:1987;70-76.
8. Scamps F, Mayoux E, Charlemagne D, Vassort G. Calcium current in single cells isolated from normal and hypertrophied rat heart effects of β-adrenergic stimulation . Circ Res. 67:1990;199-208.
9. +-currents in isolated human ventricular myocytes from patients with terminal heart failure. Cir Res. 73:1993;379-385.
10. o-induced electrical heterogeneity and extra-systolic activity in isolated canine ventricular epicardium. Circulation. 89:1994;1839-1850.
11. Aronson RS, Ming Z. Cellular mechanisms of arrhythmias in hypertrophied and failing myocardium. Circulation. 87:(Suppl VII):1993;76-83.
12. Armstrong PW, Stopps TP, Ford SE, De Bold AJ. Rapid ventricular pacing in the dog pathophysiologic studies of heart failure . Circulation. 74:1986;1075-1084.
13. Damiano RJ, Tripp HF, Asano T, Small KW, Jones RH, Lowe JE. Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia. J Thorac Cardiovasc Surg. 94:1987;135-143.
14. Wilson JR, Douglas P, Hickey WF, et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog cardiac effects . Circulation. 75:1987;857-867.
15. Riegger AJG, Liebau G. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci. 62:1982;465-469.
16. Vatner DE, Vatner SF, Fujii AM, Homcy CJ. Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure. J Clin Invest. 76:1985;2259-2264.
17. Williams RE, Kass DA, Kawagoe Y, et al. Endomyocardial gene expression during development of pacing tachycardia-induced heart failure in the dog. Circ Res. 75:1994;615-623.
18. Kääb S, Nuss HB, Chiamvimonvat N, et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 78:1996;262-273.
19. Isenberg G. Cardiac Purkinje fibers cesium as a tool to block inward rectifying potassium currents . Pflugers Arch. 365:1976;99-106.
20. Meier CF, Katzung BG. Cesium blockade of delayed outward currents and electrically-induced pacemaker activity in mammalian ventricular myocardium. J Gen Physiol. 77:1981;531-547.
21. Marban E, Tsien RW. Effects of nystatin-mediated intracellular ion substitution on membrane currents in calf Purkinje fibers. J Physiol. 329:1982;569-587.
22. Hanich RF, Levine JH, Spear JF, Moore EN. Autonomic modulation of ventricular arrhythmia in CsCl-induced long QT syndrome. Circulation. 77:1988;1149-1161.
23. Beuckelmann DJ, Näbauer M, Erdmann E. Intracellular calcium handling in ventricular myocytes from patients with terminal heart failure. Circulation. 85:1992;1046-1055.
24. Antzelevitch C, Sicouri S, Litovsky SH, et al. Heterogeneity within the ventricular wall electrophysiology and electropharmacology of epicardial, endocardial, and M cells . Circ Res. 69:1991;1227-1249.
25. Wettwer E, Amos GJ, Posival H, Ravens U. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res. 75:1994;473-482.
26. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved path-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391:1981;85-100.
27. Simpson GG, Roe A, Lewontin RC. Quantitative Zoology. 1960;440 Harcourt, Brace, Jovanovich, New York (NY).
28. Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval a marker of therapeutic efficacy in the idiopathic long QT syndrome . Circulation. 89:1994;1681-1689.
29. Brachman J, Scherlag BJ, Rosenshtraukh LV, Lazzara R. Bradycardia-dependent triggered activity relevance to drug-induced multiform ventricular tachycardia . Circulation. 68:1983;846-856.
30. Levine JH, Spear JF, Guarnieri T, et al. Cesium chloride-induced long QT syndrome demonstration of afterdepolarizations and triggered activity in vivo . Circulation. 72:1985;1092-1103.
31. Wang Z, Taylor LK, Denney WD, Hansen DE. Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle. Circulation. 90:1994;2022-2031.
32. Li HG, Jones DL, Yee R, Klein GJ. Electrophysiologic substrate associated with pacing-induced heart failure in dogs potential value of programmed stimulation in predicting sudden death . J Am Coll Cardiol. 19:1992;444-449.
33. Li HG, Jones DL, Yee R, Klein GJ. Arrhythmogenic effects of catecholamines are decreased in heart failure induced by rapid pacing in dogs. Am J Physiol. 265:1993;H1654-H1662.
34. Day CP, McComb JM, Campbell RWF. QT dispersion an indication of arrhythmia risk in patients with long QT intervals . Br Heart J. 63:1990;342-344.
35. Hii JTY, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsades de pointes disparate effects of class Ia antiarrhythmic drugs and amiodarone . Circulation. 86:1992;1376-1382.
36. Perkiomaki JS, Koistinen MJ, Yli-Mayry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol. 26:1995;174-179.
37. Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet. 345:1995;945-948.
38. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 72:1993;973-976.
39. Miorelli M, Buja G, Melacini P, Fasoli G, Nava A. QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest. Int J Cardiol. 45:1994;121-127.
40. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 343:1994;327-329.
41. Panciera DL, Refsal KR. Thyroid function in dogs with spontaneous and induced congestive heart failure. Can J Vet Res. 58:1994;157-162.
42. Wolff MR, de Tombe PP, Harasawa Y, et al. Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure. Circ Res. 70:1992;516-529.
43. O'Brien PJ, Duke AL, Shen H, Shohet RV. Myocardial mRNA content and stability, and enzyme activities of Ca-cycling and aerobic metabolism in canine dilated cardiomyopathies. Mol Cell Biochem. 142:1995;139-150.
44. Cheng CP, Pettersson K, Little WC. Effects of felodipine on LV systolic and diastolic performance in congestive heart failure. J Pharmacol Exp Ther. 271:1994;1409-1417.
45. Margulies KB, Barclay PL, Burnett JC Jr. The role of neutral endopeptidase in dogs with evolving congestive heart failure. Circulation. 91:1995;2036-2042.
46. Evans MA, Burnett JC Jr, Redfield MM. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure. J Am Coll Cardiol. 25:1995;1445-1450.
47. Spinale FG, Holzgrefe HH, Mukherjee R, et al. Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Circulation. 92:1995;562-578.
48. Roth DA, Urasawa K, Helmer GA, Hammond HK. Downregulation of cardiac guanosine 5′-triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure. J Clin Invest. 91:1993;939-949.
49. Sasayama S, Asanoi H, Ishizaka S. Continuous measurement of the pressure-volume relationship in experimental heart failure produced by rapid ventricular pacing in conscious dogs. Eur Heart J. 13:(Suppl E):1992;47-51.
50. Howard RJ, Stopps TP, Moe GW, Gotlieb A, Armstrong PW. Recovery from heart failure structural and functional analysis in a canine model . Can J Physiol Pharmacol. 66:1988;1505-1512.